Get 20% Discount on Weight Loss Market Analysis, Global Api Manufacturers and Phase Iii Pipeline Assessment, 2014

Summary

'Weight Loss- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclusivity details of all the drugs across the indication.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope

• A snapshot of the global Market therapeutics scenario for Weight Loss.

• A review of the marketed products under prescription for Weight Loss, regulatory information and marketing status.

• Coverage of global patent coverage and detailed commentaries on the US patent challenges.

• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.

• Product profiles for marketed products for Weight Loss with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.

• Coverage of API Manufacturers for Weight Loss drugs in the United States, Europe and Asian Regions with location details.

• Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Weight Loss drugs.

• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient...